NASDAQ:QTTB

Q32 Bio Stock Insider Trading

Healthcare > Biotechnology

Buy QTTB

*Your capital is at risk

$12.19

-0.450 (-3.56%)

At Close: Jun 03, 2026

Q32 Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 87.08. In total, the insiders bought 5.8M and sold 1.39M QTTB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	87.08
● Buy	5.8M shares
● Sell	1.39M shares
56% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence May 28, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 87.08. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Morrison Jodie Pope CEO	CEO / President	16 901 Value: $288.7K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Morrison Jodie Pope CEO	CEO / President	394 445 Value: $6.63M
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Xu Diyong Director	Director	12 767 Value: $32.4K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Xu Diyong Director	Director	12 767 Value: $214.7K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Iwicki Mark T Director	Director	37 222 Value: $94.5K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Iwicki Mark T Director	Director	25 534 Value: $64.9K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Iwicki Mark T Director	Director	7 615 Value: $19.3K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Iwicki Mark T Director	Director	7 615 Value: $55.5K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Iwicki Mark T Director	Director	25 534 Value: $429.5K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Campagna Jason Chief Medical Officer	Officer	87 738 Value: $222.9K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Campagna Jason Chief Medical Officer	Officer	70 687 Value: $179.5K
Feb 24, 2025 Buy	Common Stock A-Award	Campagna Jason Chief Medical Officer	Officer	37 500 Value: $95.3K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Campagna Jason Chief Medical Officer	Officer	17 951 Value: $45.6K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Campagna Jason Chief Medical Officer	Officer	70 687 Value: $1.19M
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Campagna Jason Chief Medical Officer	Officer	17 951 Value: $130.9K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Grayzel David S. Director	Director	18 595 Value: $47.2K
Feb 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Grayzel David S. Director	Director	12 767 Value: $32.4K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Lundberg Sven Ante Director	Director	12 767 Value: $214.7K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Lundberg Sven Ante Director	Director	1 316 Value: $58.4K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Lundberg Sven Ante Director	Director	23 140 Value: $74.0K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Lundberg Sven Ante Director	Director	6 238 Value: $19.5K
Feb 24, 2025 Sell	Stock Option (Right to Buy) D-Return	Lundberg Sven Ante Director	Director	2 880 Value: $21.0K
Jan 15, 2025 Buy	Stock Option (Right to Buy) A-Award	Manke Isaac Director	Director	19 008 Value: $60.8K
Jan 15, 2025 Buy	Stock Option (Right to Buy) A-Award	Manke Isaac Director	Director	19 008 Value: $60.8K
Jan 15, 2025 Buy	Stock Option (Right to Buy) A-Award	Grayzel David S. Director	Director	18 595 Value: $59.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks